Ivax albuterol net margin will be 52%; company sees 1996 approval for Elmiron.
IVAX ALBUTEROL GENERIC MDI PROFIT MARGIN OF 52% AFTER TAX is anticipated by the company, Ivax Chief Operating Officer and Health Care Group President Richard Pfenniger told the American Stock Exchange health care conference in New York City Jan. 18. The product is being manufactured by Ivax in Ireland. Ivax received approval for the first generic albuterol metered-dose inhaler Dec. 28 ("The Pink Sheet" Jan. 1, p. 3).
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth